Mankind Pharma
- Advice
- Hold
Mankind Pharma Performance
Day Range
- Low 1747.05
- High 1776.55
52 Week Range
- Low 1242
- High 1949
- Open Price1776.1
- Previous Close1742.55
- Volume84803
Start SIP in Mankind Pharma
Start SIPMankind Pharma Investment Rating
-
Master Rating:
-
Mankind Pharma Ltd has an operating revenue of Rs. 8,447.98 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 19% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Mar 2022 |
---|---|---|---|---|
Oper Rev Qtr Cr | 2,300 | 1,872 | 1,936 | 1,645 |
Operating Expenses Qtr Cr | 1,761 | 1,491 | 1,563 | 1,336 |
Operating Profit Qtr Cr | 539 | 381 | 373 | 309 |
Depreciation Qtr Cr | 69 | 67 | 71 | 36 |
Interest Qtr Cr | 2 | 1 | 9 | 11 |
Tax Qtr Cr | 117 | 74 | 77 | 53 |
Net Profit Qtr Cr | 409 | 281 | 249 | 217 |
Mankind Pharma Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹1765.97
- 50 Day
- ₹1751.09
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹1764.76
- 50 Day
- ₹1805.62
- 100 Day
- ₹
- 200 Day
- ₹
Mankind Pharma Resistance and Support
Resistance | |
---|---|
First Resistance | ₹1769.15 |
Second Resistance | ₹1787.6 |
Third Resistance | ₹1798.65 |
RSI | 46.56 |
MFI | 66.23 |
MACD Single Line | -11.26 |
MACD | -13.87 |
Support | |
---|---|
First Resistance | ₹1739.65 |
Second Resistance | ₹1728.6 |
Third Resistance | ₹1710.15 |
Mankind Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 88,665 | 5,095,578 | 57.47 |
Week | 198,488 | 13,947,738 | 70.27 |
1 Month | 280,543 | 19,851,233 | 70.76 |
6 Month | 750,403 | 40,604,315 | 54.11 |
Mankind Pharma Result Highlights
Mankind Pharma Synopsis
NSE-Medical-Products
Mankind Pharma is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 8127.15 Cr. and Equity Capital is Rs. 40.06 Cr. for the Year ended 31/03/2023. Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1991PLC044843 and registration number is 044843.Market Cap | 70,131 |
Sales | 6,109 |
Shares in Float | 9.61 |
No of funds | 177 |
Yield |
Book Value | 9.01 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | |
Alpha | 0.29 |
Beta | -0.52 |
Mankind Pharma
Owner Name | Jun-23 | May-23 |
---|---|---|
Promoters | 76.5% | 76.5% |
Mutual Funds | 3.92% | 1.83% |
Insurance Companies | 0.55% | 0.51% |
Foreign Portfolio Investors | 4.18% | 2.61% |
Financial Institutions/ Banks | 0.09% | |
Individual Investors | 1.02% | 4.15% |
Others | 13.83% | 14.31% |
Mankind Pharma Management
Name | Designation |
---|---|
Mr. Ramesh Juneja | Chairman & Wholetime Director |
Mr. Rajeev Juneja | Vice Chairman & Mng.Director |
Ms. Sheetal Arora | WholeTime Director & CEO |
Mr. Satish Kumar Sharma | Whole Time Director |
Mr. Vivek Kalra | Independent Director |
Mr. Tilokchand Punamchand Ostwal | Independent Director |
Mr. Surendra Lunia | Independent Director |
Mr. Bharat Anand | Independent Director |
Mr. Vijaya Sampath | Independent Director |
Mankind Pharma Forecast
Price Estimates
Mankind Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-02 | Quarterly Results | |
2023-05-30 | Audited Results |
- Company Name
- CMP
- Chg(%)
- Eicher Motors
- 3472
- 2.5
- Hero Motocorp
- 3034
- 2.0
- Nestle India
- 23006
- 1.6
- Bajaj Auto
- 5069
- 1.3
- O N G C
- 188
- 1.2
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1423
- -1.4
- Cipla
- 1164
- -1.3
- Tech Mahindra
- 1282
- -1.3
- Kotak Mah. Bank
- 1764
- -1.1
- Adani Enterp.
- 2458
- -1.0
Mankind Pharma FAQs
What is Share Price of Mankind Pharma ?
Mankind Pharma share price is ₹1750 As on 26 September, 2023 | 23:37
What is the Market Cap of Mankind Pharma ?
The Market Cap of Mankind Pharma is ₹70131 Cr As on 26 September, 2023 | 23:37
What is the P/E ratio of Mankind Pharma ?
The P/E ratio of Mankind Pharma is As on 26 September, 2023 | 23:37
What is the PB ratio of Mankind Pharma ?
The PB ratio of Mankind Pharma is 9.2 As on 26 September, 2023 | 23:37